Prednisolone EP Impurity D
 
		Product Description
CAT No.
				
									ALN-P027005								
				CAS No.
				
									16355-29-6								
				Mol. F.
				
									C21H28O6								
				Mol. Wt.
				
									376.4								
				Stock
				
									Please Inquire								
				
										
							
										Product Overview
						
											
										
							
										Technical Data
						
											
										
							
										Reference
						
											
										
							
										RFQ
						
									
							
							
							Product Overview
			
						
									Chemical Name : 6β,11β,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione (as per EP)								
				
									Smiles : C[C@@]12[C@](C(CO)=O)(O)CC[C@@]1([H])[C@]3([H])C[C@](O)([H])C4=CC(C=C[C@]4(C)[C@@]3([H])[C@](O)([H])C2)=O								
				
									Inchi : InChI=1S/C23H30O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h6,8,10,16-18,20,26,28H,4-5,7,9,11-12H2,1-3H3/t16-,17-,18-,20+,21-,22-,23-/m0/s1								
				
									Synonym : 6β-Hydroxyprednisolone (EP)								
				
							
							
							Technical Data
			
						
							
							
							Reference
			
						Validated stability indicating RP-LC assay for determination of gatifloxacin and prednisolone acetatein ophthalmic preparations and biological samples
									By Qadir, Muhammad A.; Shahzad, Shabnam; Ahmed, Mahmood; Razzaq, Syed S.; Shafiq, Muhmmad I.nFrom Latin American Journal of Pharmacy (2016), 35(5), 912-920								
				Novel stability indicating RP-HPLC method for the simultaneous estimation of moxifloxacin and prednisolone in bulk and their combined dosage form
									By Potnuri, Naga Raju; Rao, G. Devala; Prasad, Y. Rajendra – From International Journal of Pharmaceutical Sciences and Research (2015), 6(5), 1965-1973 								
				Development and validation of a new stability indicating reversed phase liquid chromatographic method for the determination of prednisolone acetate and impurities in an ophthalmic suspension
									By Marley, Adrian; Stalcup, Apryll M.; Connolly, Damian – From Journal of Pharmaceutical and Biomedical Analysis (2015), 102, 261-266								
				
							
							
							RFQ
			
						
 
                             
                             
                             
                             
                            